Home LiteratureArticle Details
PMID: 30620402 Published · ppublish English Journal Article

Cancer statistics, 2019.

CA: a cancer journal for clinicians ·Vol. 69 ·No. 1 ·2019-00-00 ·Pages 7-34

Siegel RL, Miller KD, Jemal A

Abstract

Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2015, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2016, were collected by the National Center for Health Statistics. In 2019, 1,762,450 new cancer cases and 606,880 cancer deaths are projected to occur in the United States. Over the past decade of data, the cancer incidence rate (2006-2015) was stable in women and declined by approximately 2% per year in men, whereas the cancer death rate (2007-2016) declined annually by 1.4% and 1.8%, respectively. The overall cancer death rate dropped continuously from 1991 to 2016 by a total of 27%, translating into approximately 2,629,200 fewer cancer deaths than would have been expected if death rates had remained at their peak. Although the racial gap in cancer mortality is slowly narrowing, socioeconomic inequalities are widening, with the most notable gaps for the most preventable cancers. For example, compared with the most affluent counties, mortality rates in the poorest counties were 2-fold higher for cervical cancer and 40% higher for male lung and liver cancers during 2012-2016. Some states are home to both the wealthiest and the poorest counties, suggesting the opportunity for more equitable dissemination of effective cancer prevention, early detection, and treatment strategies. A broader application of existing cancer control knowledge with an emphasis on disadvantaged groups would undoubtedly accelerate progress against cancer.

Keywords
cancer cases cancer statistics death rates incidence mortality
MeSH Terms
American Cancer Society Ethnicity/statistics & numerical data Female Health Status Disparities Healthcare Disparities/trends Humans Incidence Male Neoplasms/diagnosis,epidemiology,therapy Socioeconomic Factors Survival Rate United States/epidemiology
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Siegel Rebecca L ORCID
Scientific Director, Surveillance Research, American Cancer Society, Atlanta, GA.
Miller Kimberly D ORCID
Senior Associate Scientist, Surveillance Research, American Cancer Society, Atlanta, GA.
Jemal Ahmedin ORCID
Scientific Vice President, Surveillance and Health Services Research, American Cancer Society, Atlanta, GA.
Article Info
Journal
CA: a cancer journal for clinicians
Abbr.
CA Cancer J Clin
ISSN
1542-4863
Published
2019-00-00
Epub
2019-00-08
Pages
7-34
Language
English
Region
United States
NLM ID
0370647
Subset
IM
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com